Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
The Journal of Pharmacology and Experimental Therapeutics|October 18, 2006
Concentration-dependent mode of interaction of angiotensin II receptor blockers with uric acid transporterTakashi Iwanaga, Masanobu Sato, Tomoji Maeda, et al.
Archives of Toxicology|October 12, 2010
Study on species differences in nephropathy induced by FYX-051, a xanthine oxidoreductase inhibitorTakeo Shimo, Naoki Ashizawa, Mitsuyoshi Moto, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 2, 2005
Involvement of uric acid transporter in increased renal clearance of the xanthine oxidase inhibitor oxypurinol induced by a uricosuric agent, benzbromaroneTakashi Iwanaga, Daisuke Kobayashi, Masamichi Hirayama, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 18, 2006
Metabolic profile of FYX-051 (4-(5-pyridin-4-yl-1h-[1,2,4]triazol-3-yl)pyridine-2-carbonitrile) in the rat, dog, monkey, and human: identification of N-glucuronides and N-glucosidesTakashi Nakazawa, Kengo Miyata, Koichi Omura, et al.
The Journal of Pharmacy and Pharmacology|November 22, 2015
Uricosuric agents decrease the plasma urate level in rats by concomitant treatment with topiroxostat, a novel xanthine oxidoreductase inhibitorTetsuya Taniguchi, Naoki Ashizawa, Koji Matsumoto, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|October 20, 2006
Usefulness of QVAR for the treatment of bronchial asthma--with and without use of an inhalation deviceYuji Tohda, Fumio Tsuji, Hirokazu Kubo, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 2007
Characterization of N-glucuronidation of 4-(5-pyridin-4-yl-1H-[1,2,4]triazol-3-yl) pyridine-2-carbonitrile (FYX-051): a new xanthine oxidoreductase inhibitorKoichi Omura, Takashi Nakazawa, Takahiro Sato, et al.
Pharmaceutical Research|September 14, 2006
Characterization of hepatobiliary transport systems of a novel alpha4beta1/alpha4beta7 dual antagonist, TR-14035Minoru Tsuda-Tsukimoto, Tomoji Maeda, Takashi Iwanaga, et al.
The Journal of Medical Investigation : JMI|September 21, 2016
Default mode network abnormalities in children with autism spectrum disorder detected by resting-state functional magnetic resonance imagingYasuhiro Funakoshi, Masafumi Harada, Hideki Otsuka, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|August 12, 2008
Comparison of the Asthma Health Questionnaire-33-Japan and the short-form 36-item health survey for measuring quality of life in Japanese patients with asthmaMasato Muraki, Hideo Ichihashi, Ryuta Haraguchi, et al.
Pageof 13